Credit Suisse Upgrades Eli Lilly (LLY) to Outperform

Article Stock Quotes (1) Comments (0)

Earlier, Credit Suisse upgraded Eli Lilly (NYSE: LLY) from Neutral to Outperform.

For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.

Shares of Eli Lilly closed at $42.40 yesterday, with a 52 week range of $34.94-$44.67.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
• UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
• First Time Cruisers Pass on Carnival (CCL); Wells Fargo Cuts to Market Perform

Create E-mail Alert Related Categories

Upgrades

Related Entities

Credit Suisse

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?